Overview and Scope
Deoxyribonucleic acid (DNA) diagnostics refers to the application of genetic testing techniques to analyze DNA, RNA, and proteins for medical, forensic, or research purposes. These tests provide insights into genetic predispositions, disease susceptibility, and ancestry. It has revolutionized medicine and genetics, providing powerful tools for understanding and managing health and disease.
Sizing and Forecast
The DNA diagnostics market size has grown rapidly in recent years. It will grow from $20.90 billion in 2023 to $23.10 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising demand for personalized medicine, increasing adoption of genetic testing and molecular diagnostics in clinical practice, rising biomedical research, the increasing number of cancer patients, and the growing use of diagnostics tests.
The DNA diagnostics market size is expected to see rapid growth in the next few years. It will grow to $34.90 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing the prevalence of cancers, increasing demand for standardized diagnostic tests, rising prevalence of genetic disorders, increasing focus on biomarker discovery, rare diseases and orphan drugs, and growth of telemedicine and remote testing. Major trends in the forecast period include the integration of microbiome analysis, integration of blockchain technology, the integration of multiple omics data, non-invasive testing, multi-omics integration, the development of portable and point-of-care DNA diagnostic devices, and next-generation sequencing (NGS).
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report
Segmentation & Regional Insights
The DNA diagnostics market covered in this report is segmented –
1) By Product Type: Instruments, Reagents, Software And Services
2) By Technology: Polymerase Chain Reaction, Microarray, In-situ Hybridization, Sequencing Technology, Mass Spectrometry
3) By Application: Oncology, Infectious Diseases Treatment, Myogenic Disorder Treatment, Clinical Diagnostic Confirmation, Prenatal, Pre-Implantation, Other Applications
4) By End User: Point Of Care, Diagnostic Centers, Self-Testing Or Over-The-Counter (OTC)
North America was the largest region in the DNA diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=15356&type=smp
Major Driver Impacting Market Growth
The rising prevalence of genetic disorders is expected to propel the growth of the DNA diagnostics market going forward. Genetic disorders refer to health problems caused by one or more abnormalities in the genome. The rising cases of genetic disorders are due to increased diagnostic capabilities, expanded genetic testing, environmental influences, and consanguinity within populations, leading to a greater understanding and detection of genetic disorders conditions. DNA diagnostics enables the precise identification of genetic disorders through genetic material analysis, facilitating early diagnosis, personalized treatment, and informed family planning decisions. For instance, in February 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, congenital diseases caused an estimated 240,000 baby deaths globally within 28 days of birth each year. An additional 170,000 children between the ages of 1 month and 5 years die as a result of congenital diseases. Therefore, the rising prevalence of genetic disorders is driving the growth of the DNA diagnostics market.
Key Industry Players
Major companies operating in the DNA diagnostics market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Veritas Genetics
The dna diagnostics market report table of contents includes:
1. Executive Summary
2. DNA Diagnostics Market Characteristics
3. DNA Diagnostics Market Trends And Strategies
4. DNA Diagnostics Market – Macro Economic Scenario
5. Global DNA Diagnostics Market Size and Growth
.
.
.
31. DNA Diagnostics Market Other Major And Innovative Companies
32. Global DNA Diagnostics Market Competitive Benchmarking
33. Global DNA Diagnostics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The DNA Diagnostics Market
35. DNA Diagnostics Market Future Outlook and Potential Analysis
36.Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
